CompletedNCT04077437
MDMA-Assisted Therapy for PTSD: MAPP2 Phase 3 Study
About this title
Read the official source — NCT04077437Medication studyAges 18+United States + Israel
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- Los Angeles and 13 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateStarted: September 2, 2020
- Recruitment status
- Completed
- Enrollment listed in the registry
- 121
- Sponsor
- Resilient Pharmaceuticals
- Sponsor type
- Unknown or unclear
- Study type
- Behavioral
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States, Israel
- Age range
- Over 18 Years
- Official registry ID
- NCT04077437
- Official title
Show the full official title
A Randomized, Double-Blind, Placebo-Controlled, Multi-Site Phase 3 Study of the Efficacy and Safety of Manualized MDMA-Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder of Moderate or Greater Severity
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Los Angeles, United States · San Francisco, United States · Boulder, United States
9 more locations
- Fort Collins, United States
- Farmington, United States
- New Orleans, United States
- Boston, United States
- New York, United States
- Mt. Pleasant, United States
- Madison, United States
- Beer Yaaqov, Israel
- Tel HaShomer, Israel
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Resilient Pharmaceuticals.
Did this study involve medication?
Yes. The study involved medication, including Midomafetamine and Placebo.
Who was this study for?
Listed age limits: from 18 years.
